Ground Fluor Pharmaceuticals, Inc.
| 2124 Y St. Flat 101
Lincoln, NE, 68503-2495
|Socially and Economically Disadvantaged:||N|
|Number of Employees:||1|
This Small Business Innovation Research Phase II project develops positron emission tomography (PET) imaging products to manage neurodegenerative disorders, cancer, and cardiovascular disease. PET is ...SBIR Phase II 2014 National Science Foundation
This Small Business Innovation Research Phase I project will support a new synthetic chemical approach for the creation of positron emission tomography (PET) imaging products to manage neurodegenerati ...SBIR Phase I 2012 National Science Foundation